Cubist Systematic Strategies’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-32,834
Closed -$2.24M 3957
2022
Q3
$2.24M Sell
32,834
-29,655
-47% -$2.02M 0.01% 1493
2022
Q2
$2M Buy
62,489
+51,598
+474% +$1.65M 0.01% 1582
2022
Q1
$377K Sell
10,891
-26,899
-71% -$931K ﹤0.01% 2680
2021
Q4
$1.11M Sell
37,790
-140,009
-79% -$4.1M 0.01% 1842
2021
Q3
$4.53M Buy
177,799
+92,896
+109% +$2.37M 0.06% 515
2021
Q2
$2.97M Buy
84,903
+7,269
+9% +$255K 0.03% 836
2021
Q1
$3.16M Buy
77,634
+23,095
+42% +$941K 0.04% 714
2020
Q4
$2.36M Buy
54,539
+21,347
+64% +$925K 0.03% 845
2020
Q3
$1.83M Sell
33,192
-18,295
-36% -$1.01M 0.03% 965
2020
Q2
$3.25M Buy
51,487
+32,906
+177% +$2.08M 0.06% 539
2020
Q1
$949K Sell
18,581
-4,668
-20% -$238K 0.03% 869
2019
Q4
$1.85M Buy
23,249
+10,144
+77% +$806K 0.03% 794
2019
Q3
$636K Sell
13,105
-4,257
-25% -$207K 0.01% 1179
2019
Q2
$913K Buy
+17,362
New +$913K 0.02% 1099
2018
Q4
Sell
-9,410
Closed -$358K 2332
2018
Q3
$358K Buy
9,410
+1,308
+16% +$49.8K 0.02% 1032
2018
Q2
$366K Buy
+8,102
New +$366K 0.02% 959
2018
Q1
Sell
-733
Closed -$29K 2143
2017
Q4
$29K Sell
733
-5,786
-89% -$229K ﹤0.01% 1823
2017
Q3
$202K Sell
6,519
-1,686
-21% -$52.2K 0.01% 1439
2017
Q2
$224K Buy
8,205
+3,991
+95% +$109K 0.01% 1223
2017
Q1
$155K Buy
+4,214
New +$155K 0.01% 1278
2016
Q2
Sell
-5,665
Closed -$90K 1935
2016
Q1
$90K Buy
+5,665
New +$90K 0.01% 1412